MedTrace Logo

Mastectomy Reconstruction Outcomes Consortium (MROC) Study

NCT01723423 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4436

Last updated 2017-07-13

No results posted yet for this study

Summary

The MROC Study seeks to evaluate and compare from the patient's point of view the leading options for breast reconstruction after mastectomy. This study will help patients, physicians, payers and policy makers better understand the various surgeries available for breast reconstruction. Although many women choose reconstruction, the number of options as well as their pros and cons can make decision making difficult and stressful. From this research, we hope to learn more about what works best for patients undergoing these operations.

Conditions

Sponsors & Collaborators

  • Memorial Sloan Kettering Cancer Center

    collaborator OTHER

  • M.D. Anderson Cancer Center

    collaborator OTHER

  • Northwestern Memorial Hospital

    collaborator OTHER

  • Georgetown University

    collaborator OTHER

  • Ohio State University

    collaborator OTHER

  • Trinity Health Michigan

    collaborator OTHER

  • Georgia Institute for Plastic Surgery

    collaborator OTHER

  • Brigham and Women's Hospital

    collaborator OTHER

  • University of Manitoba

    collaborator OTHER

  • Providence Health & Services

    collaborator OTHER

  • University of Michigan

    lead OTHER

Principal Investigators

  • Edwin G Wilkins, MD, MS · University of Michigan

  • Andrea L. Pusic, MD, MHSA · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01723423 on ClinicalTrials.gov